Back to Agenda
Session 5: Stakeholder & Patient Engagement
Session Chair(s)
Marjon Pasmooij, PhD
Head Science Department, MEB, Netherlands
Session 5: Stakeholder & Patient Engagement
Speaker(s)
Patient Involvement in Regulatory Procedures and Impact on Regulatory Decision Making
Sharon L Gorman
, Pfizer, Inc., United Kingdom
Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making
Robbe Saesen
PhD Researcher, KU Leuven, Belgium
Stakeholder Perspectives on Implementing Precision Medicine in Diabetic Kidney Disease
Elisabeth Bakker
PhD Student, Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, Netherlands
Study to support the evaluation of the EU Orphan Regulation
Thyra de Jongh
Principal Consultant, Technopolis Group, Netherlands
Have an account?